<DOC>
	<DOCNO>NCT00603720</DOCNO>
	<brief_summary>The purpose study determine , Positron Emission Tomography ( PET ) , role nitric oxide age-associated effect fatty acid glucose delivery myocardial substrate metabolism .</brief_summary>
	<brief_title>Role Nitric Oxide Impact Aging Myocardial Remodeling</brief_title>
	<detailed_description>Aging associate increased incidence severity various cardiovascular disorder . Previously , laboratory demonstrate age-related shift substrate use heart metabolism primarily fatty acid primarily glucose . Furthermore , institution demonstrate similar shift induce , animal model , specific nitric oxide synthase inhibitor , L-NAME ( N-Nitro-L-Arginine Methyl Ester ) . Our hypothesis reduction nitric oxide ( NO ) synthesis responsible age-related shift heart function . Accordingly , aim demonstrate , young patient , acute , transient shift substrate use fatty acid glucose L-NMMA ( citrate ) association depress heart function . Also , aim demonstrate elderly acute , transient shift substrate use glucose fatty acid L-arginine , association improve cardiac function . These result demonstrate portion mechanism age-related shift substrate utilization . Each participant undergo screen visit include Glucose Tolerance Test , echocardiogram conjunction treadmill stress test exclude cardiac disease , baseline blood work . Then patient 3 PET study day , last 5-6 hour . During time , patient two IVs ( one arm ) . They 4 injection different radioactive isotope ( 015 Water , C11 Acetate , C11 Glucose , C11 Palmitate ) . After injection , 8-10 blood sample draw course Â½ 1 hour time . In injection , hour break patient rest move around . During one break , patient another echocardiogram . On day 2 3 PET , patient 30-60 minute infusion L-NAME . Then PET study commence . After study participant 10-minute infusion L-arginine reverse effect L-NAME .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<mesh_term>Oxymetazoline</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<mesh_term>NG-Nitroarginine Methyl Ester</mesh_term>
	<criteria>Between age 1835 6075 Normal glucose tolerance test Normal plasma fast lipid panel ( fast total cholesterol le 220 mg/dL ) Normal rest/stress echocardiogram BMI ( Body Mass Index ) less 30 kg/m2 Coronary artery disease High blood pressure Current smoker Diabetes mellitus Cardiovascular disease ( sign symptom kind ) History stroke , peripheral vascular disease , arrhythmia Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>PET</keyword>
	<keyword>Heart metabolism</keyword>
	<keyword>Nitric oxide</keyword>
	<keyword>Myocardial remodel</keyword>
</DOC>